• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact

crop-US-Defense-Force-Announcement

  • You are here:
  • Home
  • Ellume Announces $231.8 Million Agreement with the U.S. Government
  • crop-US-Defense-Force-Announcement

crop-US-Defense-Force-Announcement

Recent Posts
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
  • Push to allow at-home COVID tests in Australia
  • Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t
  • An Australian firm producing home COVID-19 tests for the US market has called on the federal government to reconsider its ban
  • Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons
Archives
Categories
Business
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance. © Ellume Limited 2021
ABN 13 141 767 660